2018 Q3 Form 10-Q Financial Statement

#000094480918000035 Filed on August 07, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2018 Q2 2017 Q2
Revenue $249.8M $263.7M $292.6M
YoY Change 1.53% -9.88% -11.95%
Cost Of Revenue $151.0M $150.1M $143.9M
YoY Change 11.68% 4.31% 2.08%
Gross Profit $98.90M $113.6M $148.7M
YoY Change -10.77% -23.6% -22.29%
Gross Profit Margin 39.59% 43.08% 50.82%
Selling, General & Admin $84.07M $87.65M $105.6M
YoY Change -18.52% -16.98% -10.15%
% of Gross Profit 85.01% 77.16% 71.0%
Research & Development $30.16M $29.21M $33.13M
YoY Change -7.22% -11.82% 5.68%
% of Gross Profit 30.5% 25.71% 22.28%
Depreciation & Amortization $23.92M $24.76M $25.55M
YoY Change -5.8% -3.09% 3.95%
% of Gross Profit 24.19% 21.8% 17.18%
Operating Expenses $283.3M $268.8M $318.4M
YoY Change -3.58% -15.59% 3.16%
Operating Profit -$33.46M -$5.108M -$25.83M
YoY Change -29.94% -80.23% -191.39%
Interest Expense -$3.100M -$400.0K $4.100M
YoY Change -65.93% -109.76% -612.5%
% of Operating Profit
Other Income/Expense, Net -$3.880M $8.137M $3.583M
YoY Change -54.59% 127.1% -30.06%
Pretax Income -$37.34M $3.029M -$22.25M
YoY Change -33.68% -113.61% -166.63%
Income Tax -$11.56M $2.017M -$10.96M
% Of Pretax Income 66.59%
Net Earnings -$27.66M -$6.201M -$16.92M
YoY Change -23.0% -63.34% -255.05%
Net Earnings / Revenue -11.07% -2.35% -5.78%
Basic Earnings Per Share -$0.01 -$0.03
Diluted Earnings Per Share -$49.48K -$0.01 -$0.04
COMMON SHARES
Basic Shares Outstanding 559.8M shares 559.5M shares 559.3M shares
Diluted Shares Outstanding 559.5M shares 564.2M shares

Balance Sheet

Concept 2018 Q3 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $43.70M $80.40M $130.5M
YoY Change -56.47% -38.39% -23.95%
Cash & Equivalents $43.72M $80.38M $130.5M
Short-Term Investments
Other Short-Term Assets $4.243M $4.764M $3.287M
YoY Change 9.36% 44.93% 323.58%
Inventory $43.38M $46.75M $48.29M
Prepaid Expenses
Receivables $157.4M $152.8M $251.7M
Other Receivables $24.20M $23.30M $28.00M
Total Short-Term Assets $289.8M $321.6M $472.5M
YoY Change -32.69% -31.95% -6.54%
LONG-TERM ASSETS
Property, Plant & Equipment $147.4M $150.2M $133.4M
YoY Change 3.47% 12.6% 3.96%
Goodwill $713.6M $714.2M $712.1M
YoY Change -0.27% 0.3% 3.04%
Intangibles
YoY Change
Long-Term Investments $41.20M $43.70M $31.00M
YoY Change 36.42% 40.97% -7.19%
Other Assets $9.652M $5.246M $39.16M
YoY Change -74.8% -86.6% 793.09%
Total Long-Term Assets $2.191B $2.209B $2.296B
YoY Change -4.38% -3.78% 1.22%
TOTAL ASSETS
Total Short-Term Assets $289.8M $321.6M $472.5M
Total Long-Term Assets $2.191B $2.209B $2.296B
Total Assets $2.481B $2.531B $2.769B
YoY Change -8.85% -8.59% -0.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $65.61M $69.06M $62.15M
YoY Change -1.39% 11.11% 1.79%
Accrued Expenses $214.9M $201.0M $206.4M
YoY Change 21.9% -2.62% -1.64%
Deferred Revenue $61.73M $61.85M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $40.80M $40.00M $14.50M
YoY Change 153.23% 175.94% 40.37%
Total Short-Term Liabilities $317.8M $306.9M $283.1M
YoY Change 22.74% 8.41% 0.65%
LONG-TERM LIABILITIES
Long-Term Debt $1.142M $1.704M $1.560M
YoY Change -1.72% 9.23% -13.67%
Other Long-Term Liabilities $183.8M $209.4M $201.8M
YoY Change -18.89% 3.77% -10.02%
Total Long-Term Liabilities $374.5M $413.6M $378.8M
YoY Change 0.14% 9.18% -20.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $317.8M $306.9M $283.1M
Total Long-Term Liabilities $374.5M $413.6M $378.8M
Total Liabilities $692.4M $720.5M $661.9M
YoY Change 9.38% 8.85% -12.73%
SHAREHOLDERS EQUITY
Retained Earnings -$1.109B -$1.081B -$745.9M
YoY Change 39.96% 44.97% 6.36%
Common Stock $5.604M $5.602M $5.600M
YoY Change 0.07% 0.04% 2.13%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.791M $1.791M $1.791M
YoY Change 0.0% 0.0% -6.28%
Treasury Stock Shares 549.9K shares 549.9K shares 549.9K shares
Shareholders Equity $1.789B $1.811B $2.107B
YoY Change
Total Liabilities & Shareholders Equity $2.481B $2.531B $2.769B
YoY Change -8.85% -8.59% -0.19%

Cashflow Statement

Concept 2018 Q3 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$27.66M -$6.201M -$16.92M
YoY Change -23.0% -63.34% -255.05%
Depreciation, Depletion And Amortization $23.92M $24.76M $25.55M
YoY Change -5.8% -3.09% 3.95%
Cash From Operating Activities -$21.90M -$17.10M -$22.70M
YoY Change -41.76% -24.67% -153.04%
INVESTING ACTIVITIES
Capital Expenditures -$12.00M -$6.800M -$7.300M
YoY Change -21.57% -6.85% 135.48%
Acquisitions
YoY Change
Other Investing Activities $500.0K $300.0K -$2.700M
YoY Change -145.45% -111.11% -86.83%
Cash From Investing Activities -$11.50M -$6.600M -$10.00M
YoY Change -29.45% -34.0% -57.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.000M 4.000M 31.70M
YoY Change -113.1% -87.38% -183.42%
NET CHANGE
Cash From Operating Activities -21.90M -17.10M -22.70M
Cash From Investing Activities -11.50M -6.600M -10.00M
Cash From Financing Activities -3.000M 4.000M 31.70M
Net Change In Cash -36.40M -19.70M -1.000M
YoY Change 17.42% 1870.0% -94.68%
FREE CASH FLOW
Cash From Operating Activities -$21.90M -$17.10M -$22.70M
Capital Expenditures -$12.00M -$6.800M -$7.300M
Free Cash Flow -$9.900M -$10.30M -$15.40M
YoY Change -55.61% -33.12% -133.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000944809
CY2018Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
559770995 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Opko Health, Inc.
CY2017Q4 opk Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
12191000 USD
CY2018Q2 opk Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
11598000 USD
opk Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Estimated Future Sales Decrease Ten Percent
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfEstimatedFutureSalesDecreaseTenPercent
1700000 USD
CY2017Q4 opk Business Combination Deferred Acquisition Payments Netof Discount Current
BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent
4868000 USD
CY2018Q2 opk Business Combination Deferred Acquisition Payments Netof Discount Current
BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent
4967000 USD
CY2017Q4 opk Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets
2000000000 USD
CY2018Q2 opk Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets
2000000000 USD
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
806000 USD
opk Contingent Membership Interest
ContingentMembershipInterest
0.15
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
0 USD
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
0 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
146000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4725000 shares
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
1546000 USD
CY2017Q2 opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-11288000 USD
opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-43661000 USD
CY2017Q4 opk Debt Instruments Numberof Financial Institutions
DebtInstrumentsNumberofFinancialInstitutions
11 institution
CY2018Q2 opk Debt Instruments Numberof Financial Institutions
DebtInstrumentsNumberofFinancialInstitutions
11 institution
CY2018Q2 opk Equity Method Investment Excluding Variable Interest Entity
EquityMethodInvestmentExcludingVariableInterestEntity
19703000 USD
CY2018Q2 opk Equity Method Investment Variable Interest Entity
EquityMethodInvestmentVariableInterestEntity
706000 USD
CY2018Q2 opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
1012000 USD
opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-39646000 USD
opk Increase Decrease In Equity Securities Fvni And Derivative Instruments
IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments
9519000 USD
opk Increase Decrease In Equity Securities Fvni And Derivative Instruments
IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments
14819000 USD
opk Increase Decreasein Foreign Currency Measurement
IncreaseDecreaseinForeignCurrencyMeasurement
230000 USD
opk Increase Decreasein Foreign Currency Measurement
IncreaseDecreaseinForeignCurrencyMeasurement
-77000 USD
CY2017Q2 opk Interest Expense Nonoperating
InterestExpenseNonoperating
1502000 USD
opk Interest Expense Nonoperating
InterestExpenseNonoperating
2931000 USD
CY2018Q2 opk Interest Expense Nonoperating
InterestExpenseNonoperating
2722000 USD
opk Interest Expense Nonoperating
InterestExpenseNonoperating
4989000 USD
CY2017Q2 opk Interest Income Nonoperating
InterestIncomeNonoperating
136000 USD
opk Interest Income Nonoperating
InterestIncomeNonoperating
385000 USD
CY2018Q2 opk Interest Income Nonoperating
InterestIncomeNonoperating
27000 USD
opk Interest Income Nonoperating
InterestIncomeNonoperating
67000 USD
opk Numberof Sales Employees
NumberofSalesEmployees
400 employee
CY2017Q2 opk Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax
0 USD
opk Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax
0 USD
CY2018Q2 opk Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax
0 USD
opk Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax
4876000 USD
CY2018Q2 opk Percentage Of Increase Decrease In Future Sales
PercentageOfIncreaseDecreaseInFutureSales
-0.1
CY2017Q4 opk Proceeds From Development And License Agreement Upfront Payment
ProceedsFromDevelopmentAndLicenseAgreementUpfrontPayment
6000000 USD
CY2017Q2 opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
187875 shares
opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
272857 shares
CY2018Q2 opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
186323 shares
opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
186323 shares
CY2017Q2 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
539500 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
1646372 shares
CY2018Q2 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
332000 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
332000 shares
CY2017Q2 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
351625 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
1373515 shares
CY2018Q2 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
145677 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
145677 shares
CY2018Q2 opk Stock Optionand Warrant Investments
StockOptionandWarrantInvestments
1799000 USD
CY2017Q4 opk Taxes Recoverable Current
TaxesRecoverableCurrent
18138000 USD
CY2018Q2 opk Taxes Recoverable Current
TaxesRecoverableCurrent
21319000 USD
CY2017Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
8798000 USD
CY2018Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2031000 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
74307000 USD
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
69061000 USD
CY2017Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
166962000 USD
CY2018Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
154269000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
165516000 USD
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
152777000 USD
CY2017Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
50377000 USD
CY2018Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
46621000 USD
CY2017Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4609000 USD
CY2018Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3604000 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
230301000 USD
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
200992000 USD
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2355000 USD
CY2018Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1727000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-528000 USD
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13004000 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2889256000 USD
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2901086000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15800000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11500000 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1400000 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1446000 USD
CY2018Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1492000 USD
CY2018Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1500000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
112000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
99000 USD
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17953000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35881000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35900000 USD
CY2018Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17227000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
34500000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
34498000 USD
CY2017Q4 us-gaap Assets
Assets
2589956000 USD
CY2018Q2 us-gaap Assets
Assets
2530950000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
348861000 USD
CY2018Q2 us-gaap Assets Current
AssetsCurrent
321562000 USD
CY2017Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4366000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
6738000 USD
CY2018Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-15358000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-13599000 USD
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
41400000 USD
CY2018Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
27700000 USD
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
11750000 USD
CY2018Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
2042000 USD
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
29603000 USD
CY2018Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
25712000 USD
CY2017Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3399000 USD
CY2018Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3166000 USD
CY2017Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
7786000 USD
CY2018Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
6638000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
168733000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130530000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91499000 USD
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80381000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-38203000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11118000 USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
560023745 shares
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
560169422 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
5600000 USD
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
5602000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-6033000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-38480000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-18666000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-61791000 USD
CY2017Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
140400000 USD
CY2018Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
109600000 USD
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
61388000 USD
CY2018Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
61846000 USD
CY2017Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
78990000 USD
CY2018Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
47720000 USD
CY2017Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
29160000 USD
CY2018Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
55894000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23039000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2026000 USD
CY2017Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
148729000 USD
CY2018Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
148255000 USD
us-gaap Depreciation
Depreciation
15400000 USD
us-gaap Depreciation
Depreciation
15000000 USD
CY2017Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25551000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
51281000 USD
CY2018Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24762000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
49518000 USD
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
877000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-64000 USD
CY2017Q2 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-5069000 USD
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-10014000 USD
CY2018Q2 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
0 USD
CY2018Q2 us-gaap Equity Method Investment Quoted Market Value
EquityMethodInvestmentQuotedMarketValue
40100000 USD
CY2018Q2 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
363300000 USD
CY2018Q2 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
174600000 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-143500000 USD
CY2018Q2 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
15547000 USD
CY2018Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
22350000 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
11289000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
11402000 USD
CY2018Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
939000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
198935000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
231996000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
683835000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
648541000 USD
CY2017Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
5482000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
9519000 USD
CY2018Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2248000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3644000 USD
CY2017Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-5628000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-7758000 USD
CY2018Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-7213000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-9669000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-113000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2473000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
495000 USD
CY2017Q4 us-gaap Goodwill
Goodwill
717099000 USD
CY2018Q2 us-gaap Goodwill
Goodwill
714234000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-2865000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-22248000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-61565000 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3029000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-38520000 USD
CY2017Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5628000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7758000 USD
CY2018Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7213000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9669000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10960000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-17904000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2017000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1126000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4321000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5251000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9439000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8092000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30865000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-12440000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3837000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-15820000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-31122000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3692000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3730000 USD
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4816000 shares
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-30812000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
443000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-894000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
254000 USD
CY2018Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2017Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
647347000 USD
CY2018Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
645714000 USD
CY2017Q2 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
652000 USD
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
1291000 USD
CY2018Q2 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 USD
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 USD
us-gaap Interest Paid
InterestPaid
748000 USD
us-gaap Interest Paid
InterestPaid
785000 USD
CY2017Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
21012000 USD
CY2018Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
16783000 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
49333000 USD
CY2018Q2 us-gaap Inventory Net
InventoryNet
46753000 USD
CY2017Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
7467000 USD
CY2018Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
5800000 USD
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
6565000 USD
CY2018Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4726000 USD
CY2017Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
5873000 USD
CY2018Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
3910000 USD
us-gaap Inventory Write Down
InventoryWriteDown
4800000 USD
us-gaap Inventory Write Down
InventoryWriteDown
1200000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
734378000 USD
CY2018Q2 us-gaap Liabilities
Liabilities
720454000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2589956000 USD
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2530950000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
316534000 USD
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
306861000 USD
CY2017Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
417844000 USD
CY2018Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
413593000 USD
CY2017Q4 us-gaap Line Of Credit
LineOfCredit
114664000 USD
CY2018Q2 us-gaap Line Of Credit
LineOfCredit
109496000 USD
CY2018Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
196900000 USD
CY2017Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
11926000 USD
CY2018Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
6465000 USD
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1567000 USD
CY2018Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1704000 USD
CY2017Q4 us-gaap Long Term Investments
LongTermInvestments
40642000 USD
CY2018Q2 us-gaap Long Term Investments
LongTermInvestments
45497000 USD
CY2017Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
104152000 USD
CY2018Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
105539000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33915000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
53211000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16412000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11666000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-56583000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-52599000 USD
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16916000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-51419000 USD
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6201000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-49315000 USD
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-21333000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-60142000 USD
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6201000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-49315000 USD
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3583000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9482000 USD
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8137000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9199000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
318432000 USD
us-gaap Operating Expenses
OperatingExpenses
630028000 USD
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
268793000 USD
us-gaap Operating Expenses
OperatingExpenses
566317000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-25831000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-71047000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5108000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-47719000 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
79364000 USD
CY2018Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
65421000 USD
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3838000 USD
CY2018Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4764000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5615000 USD
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5246000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10495000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13088000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12465000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7600000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-594000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-594000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
CY2017Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-206000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-743000 USD
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2017Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
21546000 USD
CY2018Q2 us-gaap Other Inventory Supplies
OtherInventorySupplies
24986000 USD
CY2017Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
17857000 USD
CY2018Q2 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
22131000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
239955000 USD
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
209444000 USD
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-533000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2509000 USD
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8584000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10477000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
1294000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
2198000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3000000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1000000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
16805000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
12792000 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
42513000 USD
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
41651000 USD
CY2017Q4 us-gaap Prepaid Insurance
PrepaidInsurance
3532000 USD
CY2018Q2 us-gaap Prepaid Insurance
PrepaidInsurance
3259000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
55000000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1916000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
318000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
45524000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
18817000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1286000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3398000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
840000 USD
CY2017Q2 us-gaap Profit Loss
ProfitLoss
-16916000 USD
us-gaap Profit Loss
ProfitLoss
-51419000 USD
CY2018Q2 us-gaap Profit Loss
ProfitLoss
-6201000 USD
us-gaap Profit Loss
ProfitLoss
-49315000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
146557000 USD
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
150156000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
500000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
200000 USD
CY2018Q2 us-gaap Purchase Obligation
PurchaseObligation
84400000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
13525000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
20924000 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33128000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
59685000 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29211000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
62097000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1036959000 USD
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1081397000 USD
CY2017Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
292601000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
558981000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
263685000 USD
us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
0 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
518598000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
179172000 USD
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
105579000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
215523000 USD
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
87653000 USD
CY2017Q4 us-gaap Senior Notes Current
SeniorNotesCurrent
0 USD
CY2018Q2 us-gaap Senior Notes Current
SeniorNotesCurrent
30343000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
15844000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
11514000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1855578000 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1810496000 USD
CY2017Q4 us-gaap Supplies
Supplies
8207000 USD
CY2018Q2 us-gaap Supplies
Supplies
10278000 USD
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
549907 shares
CY2018Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
549907 shares
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1791000 USD
CY2018Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1791000 USD
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
564164000 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
564163808 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
563617000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
563617274 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
559541000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
559541253 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
559508000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
559507732 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
559347540 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
559348000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
558892375 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
558892000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
559541253 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
559541000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
559508000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
559507732 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</font><font style="font-family:inherit;font-size:10pt;">. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from these estimates.</font></div></div>

Files In Submission

Name View Source Status
0000944809-18-000035-index-headers.html Edgar Link pending
0000944809-18-000035-index.html Edgar Link pending
0000944809-18-000035.txt Edgar Link pending
0000944809-18-000035-xbrl.zip Edgar Link pending
amendmentno7tobrlijpmcredi.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
opk-20180630.xml Edgar Link completed
opk-20180630.xsd Edgar Link pending
opk-20180630_cal.xml Edgar Link unprocessable
opk-20180630_def.xml Edgar Link unprocessable
opk-20180630_lab.xml Edgar Link unprocessable
opk-20180630_pre.xml Edgar Link unprocessable
opk-6302018x10q.htm Edgar Link pending
opk-6302018xex311.htm Edgar Link pending
opk-6302018xex312.htm Edgar Link pending
opk-6302018xex321.htm Edgar Link pending
opk-6302018xex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending